Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer: A Review

IMPORTANCE: Non–small cell lung cancer remains the leading cause of cancer death in the United States. Until the last decade, the 5-year overall survival rate for patients with metastatic non–small cell lung cancer was less than 5%. Improved understanding of the biology of lung cancer has resulted i...

Full description

Saved in:

Bibliographic Details
Published in:	JAMA : the journal of the American Medical Association 2019-08, Vol.322 (8), p.764-774
Main Authors:	Arbour, Kathryn C, Riely, Gregory J
Format:	Article
Language:	English
Subjects:	ALK protein Apoptosis Biology Biomarkers Cancer therapies Carboplatin Chemotherapy Cisplatin Cytotoxicity Enzyme inhibitors Epidermal growth factor receptors Gefitinib Immune checkpoint inhibitors Inhibitors Kinases Lung cancer Medical treatment Metastases Metastasis Mutation PD-L1 protein Platinum Protein-tyrosine kinase Proteins Survival Tumors Tyrosine
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!